Himanshu Doshi, MD
Anatomic Pathology & Clinical Pathology · Steubenville, OHNPI 1508865551
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 31 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 15.3% — the pattern of someone who eats at a lot of different presentations. Among anatomic pathology & clinical pathology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 31 payments — averaging $23.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eisai Inc.$113
- Novartis$95
- Astellas Pharma US Inc$87
- Foundation Medicine, Inc.$64
- EMD Serono, Inc.$43
- Seagen Inc.$41
- plus $297 from 12 others
What the payments were for
- Food & beverage$72798%
- Education$142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eisai Inc. | 5 | $113 |
| Novartis | 4 | $95 |
| Astellas Pharma US Inc | 3 | $87 |
| Foundation Medicine, Inc. | 1 | $64 |
| EMD Serono, Inc. | 2 | $43 |
| Seagen Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Exelixis Inc. | 2 | $37 |
| Biomerieux Inc | 1 | $36 |
| Merck | 2 | $34 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $26 |
| Incyte Corporation | 1 | $21 |
| Bayer | 1 | $19 |
| Tesaro, Inc. | 1 | $15 |
| CTI Biopharma Corp. | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
How this compares
$741 in reported general payments places this provider in the 90th percentile of 325 anatomic pathology & clinical pathology providers in Ohio.
See all anatomic pathology & clinical pathology providers in Ohio →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Steubenville
- Adrienne JordanDayton$450K
- Richard PelstringKettering$212K
- Gary TozbikianColumbus$123K
- Faizi AliLorain$90K
- Anil ParwaniColumbus$72K
- Priscilla WaldhegerElyria$63K
- Giovanni LujanColumbus$18K
- Erin GoodhueColumbus$16K
- Divya SharmaCincinnati$10K
- Zaibo LiColumbus$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.